Cargando…
Fibrinolysis in a lipid environment: modulation through release of free fatty acids
Background: Thrombolysis is conventionally regarded as dissolution of the fibrin matrix of thrombi by plasmin, but the structure of clots in vivo includes additional constituents (proteins, phospholipids) that modulate their solubilization. Objective: We examined the presence of free fatty acids in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974781/ https://www.ncbi.nlm.nih.gov/pubmed/17403096 http://dx.doi.org/10.1111/j.1538-7836.2007.02556.x |
_version_ | 1782135040610664448 |
---|---|
author | RÁBAI, G VÁRADI, B LONGSTAFF, C SÓTONYI, P KRISTÓF, V TIMÁR, F MACHOVICH, R KOLEV, K |
author_facet | RÁBAI, G VÁRADI, B LONGSTAFF, C SÓTONYI, P KRISTÓF, V TIMÁR, F MACHOVICH, R KOLEV, K |
author_sort | RÁBAI, G |
collection | PubMed |
description | Background: Thrombolysis is conventionally regarded as dissolution of the fibrin matrix of thrombi by plasmin, but the structure of clots in vivo includes additional constituents (proteins, phospholipids) that modulate their solubilization. Objective: We examined the presence of free fatty acids in thrombi and their effects on distinct stages of fibrinolysis (plasminogen activation, plasmin activity). Methods and Results: Using the fluorescent probe acrylodated intestinal fatty acid-binding protein, variable quantities (up to millimolar concentrations) of free fatty acids were demonstrated in surgically removed human thrombi. Oleic acid at relevant concentrations reversibly inhibits more than 90% of the amidolytic activity of plasmin on a synthetic substrate (Spectrozyme PL), but only partially inhibits its fibrinolytic activity measured using turbidimetry. Chromogenic assays detecting the generated plasmin activity show that plasminogen activation by tissue-type plasminogen activator (t-PA) is completely blocked by oleic acid in the fluid phase, but is accelerated on a fibrin matrix. A recombinant derivative of t-PA (reteplase) develops higher fibrin specificity in the presence of oleic acid, because both the inhibition of plasminogen activation in free solution and its enhancement on fibrin template are stronger than with wild-type t-PA. Conclusion: Through the stimulation of plasminogen activation on a fibrin template and the inhibition of plasminogen activators and plasmin in the fluid phase, free fatty acids confine the action of fibrinolytic proteases to the site of clotting, where they partially oppose the thrombolytic barrier function of phospholipids. |
format | Text |
id | pubmed-1974781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-19747812007-09-10 Fibrinolysis in a lipid environment: modulation through release of free fatty acids RÁBAI, G VÁRADI, B LONGSTAFF, C SÓTONYI, P KRISTÓF, V TIMÁR, F MACHOVICH, R KOLEV, K J Thromb Haemost Fibrinolysis Background: Thrombolysis is conventionally regarded as dissolution of the fibrin matrix of thrombi by plasmin, but the structure of clots in vivo includes additional constituents (proteins, phospholipids) that modulate their solubilization. Objective: We examined the presence of free fatty acids in thrombi and their effects on distinct stages of fibrinolysis (plasminogen activation, plasmin activity). Methods and Results: Using the fluorescent probe acrylodated intestinal fatty acid-binding protein, variable quantities (up to millimolar concentrations) of free fatty acids were demonstrated in surgically removed human thrombi. Oleic acid at relevant concentrations reversibly inhibits more than 90% of the amidolytic activity of plasmin on a synthetic substrate (Spectrozyme PL), but only partially inhibits its fibrinolytic activity measured using turbidimetry. Chromogenic assays detecting the generated plasmin activity show that plasminogen activation by tissue-type plasminogen activator (t-PA) is completely blocked by oleic acid in the fluid phase, but is accelerated on a fibrin matrix. A recombinant derivative of t-PA (reteplase) develops higher fibrin specificity in the presence of oleic acid, because both the inhibition of plasminogen activation in free solution and its enhancement on fibrin template are stronger than with wild-type t-PA. Conclusion: Through the stimulation of plasminogen activation on a fibrin template and the inhibition of plasminogen activators and plasmin in the fluid phase, free fatty acids confine the action of fibrinolytic proteases to the site of clotting, where they partially oppose the thrombolytic barrier function of phospholipids. Blackwell Publishing Ltd 2007-06-01 /pmc/articles/PMC1974781/ /pubmed/17403096 http://dx.doi.org/10.1111/j.1538-7836.2007.02556.x Text en © 2007 The Authors. Journal Compilation © 2007 International Society on Thrombosis and Haemostasis https://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Fibrinolysis RÁBAI, G VÁRADI, B LONGSTAFF, C SÓTONYI, P KRISTÓF, V TIMÁR, F MACHOVICH, R KOLEV, K Fibrinolysis in a lipid environment: modulation through release of free fatty acids |
title | Fibrinolysis in a lipid environment: modulation through release of free fatty acids |
title_full | Fibrinolysis in a lipid environment: modulation through release of free fatty acids |
title_fullStr | Fibrinolysis in a lipid environment: modulation through release of free fatty acids |
title_full_unstemmed | Fibrinolysis in a lipid environment: modulation through release of free fatty acids |
title_short | Fibrinolysis in a lipid environment: modulation through release of free fatty acids |
title_sort | fibrinolysis in a lipid environment: modulation through release of free fatty acids |
topic | Fibrinolysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974781/ https://www.ncbi.nlm.nih.gov/pubmed/17403096 http://dx.doi.org/10.1111/j.1538-7836.2007.02556.x |
work_keys_str_mv | AT rabaig fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT varadib fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT longstaffc fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT sotonyip fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT kristofv fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT timarf fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT machovichr fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids AT kolevk fibrinolysisinalipidenvironmentmodulationthroughreleaseoffreefattyacids |